Introduction
Mambwe Mutanuka-Hiebel represents healthcare providers in various regulatory and transactional matters.
My focus
I focus on transactional and regulatory matters for healthcare providers, private equity firms, and others in the health services, technology, and life sciences industries. The scope of my work includes joint ventures, mergers and acquisitions, and other strategic transactions. I also assist clients with general corporate law and governance issues.
Prior to practicing law, I served as a corporate director of contracting in governance, risk, and compliance for a large nonprofit healthcare system. In my role, I partnered with in-house and external counsel, executives, and other subject matter experts to ensure corporate objectives were achieved during contract negotiations. My corporate experience allows me to serve clients with their regulatory and transactional needs while maintaining a unique perspective on business operational needs.
Looking ahead
The legal and regulatory landscape continues to evolve to address the multitude of risks associated with the emerging technology healthcare market. I anticipate the continued entry of non-healthcare technology companies into the healthcare technology space, particularly at the consumer level. Federal and state laws, regulations, and policies will continue to evolve in direct response to this ever-changing environment. Companies will need to maintain robust yet nimble compliance and security policies to accommodate these changes.
In the news
- The Journal of Federal Agency Action
False Claims Act recoveries hit records in 2025, Justice Department announces
March 30, 2026Government Investigations & White-Collar Defense partner Adam Tarosky of Washington, DC, leader of NP’s False Claims Act team, and counsel Brianna Portu of Boston; Complex Disputes partner Jonah Retzinger of Los Angeles; and Healthcare partner Harsh Parikh of Los Angeles and associate Mambwe Mutanuka-Hiebel of New York City contributed this article discussing False Claims Act settlements and judgements for 2025.
- NJ.com
ADHD patients in NJ will soon have a harder time getting Adderall and Ritalin
March 19, 2026This article covers New Jersey’s changing rules that will mandate in-person examinations for Schedule II controlled substances. The article references and quotes a NP alert on the topic by Long Island partners Rebecca Simone and Michele Masucci, New York City partner Jéna Grady and associate Mambwe Mutanuka-Hiebel, and Los Angeles associate Sravya Rallapalli, all of the Healthcare practice.
- California Health Law News
Navigating tariffs and False Claims Act risk in the healthcare supply chain
June 18, 2025Los Angeles Complex Disputes partner Jonah Retzinger, Government Investigation & White-Collar Defense partners Chris Grigg of Los Angeles and Adam Tarosky of Washington, DC, and Chicago Healthcare associate Mambwe Mutanuka contributed this article discussing best practices for navigating tariffs and False Claims Act risk in the healthcare supply chain.
Admitted to practice
Illinois
New York
Education
Loyola University Chicago School of Law, J.D., Transactional Law Certificate, magna cum laude
University of West Florida, M.B.A.
University of West Florida, B.A.
Recognition
- Selected as a 2025 Pathfinder for the Leadership Council on Legal Diversity (LCLD)
- Four-time CALI Excellence for the Future Award Recipient
- Beazley Institute for Health Law and Policy Fellow
- Executive Editor, Loyola University Chicago School of Law Annals of Health Law and Life Sciences
Insights And Happenings
View AllProfessionals in the Practice Area
View AllLindsay Maleson
Partner / Practice Group Leader, Healthcare- Long Island
- Long Island +1 516.832.7627
- lmaleson@nixonpeabody.com
-
Jill H. Gordon
Senior Counsel / Co-chair, Life Sciences Practice- Los Angeles
- Los Angeles +1 213.629.6175
- jgordon@nixonpeabody.com
-
Harsh P. Parikh
Partner- Los Angeles
- Los Angeles +1 213.629.6108
- San Francisco +1 415.984.5024
- hparikh@nixonpeabody.com
-
